Tier 3 · Filer Universe

Lineage Cell Therapeutics, Inc.

LCTX · NYSE American · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$1.06
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0000876343
Liquidity rank
#4065
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$14.56M2025-12-310001193125-26-093992
Annual diluted EPS-0.282025-12-310001193125-26-093992
Quarterly revenue$1.07M2026-06-300001193125-26-338064
Quarterly diluted EPS-0.032026-06-300001193125-26-338064

SEC EDGAR Frames batch generated 2026-08-10T23:34:18.959Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNYSE AmericanDHR · Tier 1 peerABT · Tier 1 peerBMY · Tier 1 peerTMO · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames